Related Experiment Video
Updated: May 13, 2025

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
City scale related to epidermal growth factor receptor mutations status in Chinese non-small cell lung cancer
Guang-Gui Ding1, Jie-Lun Wen2, Rui Gong3
1Department of Thoracic Surgery, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of South University of Science and Technology, Shenzhen, Guangdong, China.
Purpose:
This study aimed to explore the relationship between city scale and epidermal growth factor receptor (EGFR) mutation status in Chinese patients with non-small cell lung cancer (NSCLC).
Methods:
A retrospective study enrolled NSCLC patients who underwent tissue EGFR mutation testing at Sun Yat-sen University Cancer Center from 2012 to 2017. City scale was categorized according to classifications made by the State Council of China in 2014. Multivariable logistic regression was utilized to determine independent predictors of EGFR mutation status in NSCLC patients.
Results:
A total of 4637 NSCLC patients were enrolled in this study. EGFR mutation related to gender, smoking statue, histological type, and city scale. Higher rate of EGFR mutations among patients of super large-sized and very large-sized cities compared to other cities. There was an inverse relationship between city scale and smoking status among patients. Multivariate analysis showed that city scale was not an independent predictor of EGFR mutation.
Conclusions:
Although there is a correlation between the size of a city and the rates of EGFR mutations in Chinese NSCLC patients, city scale does not independently predict these mutation rates. Instead, the variations in EGFR mutation rates could be indirectly related to different levels of urbanization, which may influence smoking behaviors among the populations.
More Related Videos
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Related Concept Videos
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Ras Gene
Ras is a...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation